January 2011 Amplyx Pharmaceuticals has received a new investment
from Savannah Angels and has raised over $2.2 M in Series A financing
January 2011 Amplyx receives over $400,000 from the Qualifying Therapeutic
Discovery Project Grant Program
January 2011 Amplyx presents at the 2011 Biocom Global Partnering Conference in San Diego
June 2011 Amplyx to attend Bio 2011 in Washington, D.C.
July 2011 Amplyx is awarded a Phase I SBIR from the NIH to develop
novel antifungal therapeutics
